Osimertinib for NSCLC With Uncommon EGFR Mutations
- Status
- SUSPENDED
- Phase
- N/A
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
A Study to Investigate the Absolute Bioavailability, Absorption, Metabolism, Distribution and Excretion of [14C]AZD5363 (Capivasertib)
- Status
- COMPLETED
- Phase
- PHASE1
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Tracking Treatment Pathways in Adult Patients With Hyperkalemia.
- Status
- COMPLETED
- Phase
- N/A
Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC
- Status
- SUSPENDED
- Phase
- PHASE1
Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma
- Status
- TERMINATED
- Phase
- PHASE3
A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and Digoxin
- Status
- COMPLETED
- Phase
- PHASE1
Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic Patients
- Status
- TERMINATED
- Phase
- PHASE4
PASS of Paediatric Patients Initiating Selumetinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
FAsenra Safety Trial in India
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibitor Therapy (Re-Check)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19
- Status
- TERMINATED
- Phase
- PHASE2
Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2